In this study, we explore haploidentical allogeneic HSCT in NBL-bearing mice as a means of insuring that some of the inhibitory Ly49 receptors on donor murine NK cells do not engage their cognate MHC ligand, potentially “turning on” the NK cells and maximizing anti-tumor activity after hu14.18-IL2 IC administration. Here, IL2 is linked to neoplasm.